Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Oct;16(10):623-32.
doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes

Collaborators, Affiliations
Multicenter Study

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes

H Peter Chase et al. Diabetes Technol Ther. 2014 Oct.

Abstract

Background: This study evaluated meal bolus insulin delivery strategies and associated postprandial glucose control while using an artificial pancreas (AP) system.

Subjects and methods: This study was a multicenter trial in 53 patients, 12-65 years of age, with type 1 diabetes for at least 1 year and use of continuous subcutaneous insulin infusion for at least 6 months. Four different insulin bolus strategies were assessed: standard bolus delivered with meal (n=51), standard bolus delivered 15 min prior to meal (n=40), over-bolus of 30% delivered with meal (n=40), and bolus purposely omitted (n=46). Meal carbohydrate (CHO) intake was 1 g of CHO/kg of body weight up to a maximum of 100 g for the first three strategies or up to a maximum of 50 g for strategy 4.

Results: Only three of 177 meals (two with over-bolus and one with standard bolus 15 min prior to meal) had postprandial blood glucose values of <60 mg/dL. Postprandial hyperglycemia (blood glucose level >180 mg/dL) was prolonged for all four bolus strategies but was shorter for the over-bolus (41% of the 4-h period) than the two standard bolus strategies (73% for each). Mean postprandial blood glucose level was 15.9 mg/dL higher for the standard bolus with meal compared with the prebolus (baseline-adjusted, P=0.07 for treatment effect over the 4-h period).

Conclusions: The AP handled the four bolus situations safely, but at the expense of having elevated postprandial glucose levels in most subjects. This was most likely secondary to suboptimal performance of the algorithm.

Trial registration: ClinicalTrials.gov NCT01271023.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Glycemic control following standard bolus delivered with and before breakfast: (top panel) glucose levels and (bottom panel) insulin delivery following breakfast. Lines with dots denote the median glucose, lines without dots denote the 25th and 75th percentiles for glucose, and bars denote mean insulin delivery.
<b>FIG. 2.</b>
FIG. 2.
Glycemic control following over-bolus and no bolus delivered with breakfast: (top panel) glucose levels and (bottom panel) insulin delivery following breakfast. Lines with dots denote the median glucose, lines without dots denote the 25th and 75th percentiles for glucose, and bars denote mean insulin delivery.

References

    1. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(Suppl 1):S11–S66 - PMC - PubMed
    1. Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, Chase HP: Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther 2010;12:173–177 - PubMed
    1. Luijf YM, van Bon AC, Hoekstra JB, Devries JH: Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 2010;33:2152–2155 - PMC - PubMed
    1. Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK: Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33:1282–1287 - PMC - PubMed
    1. Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L: Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 2013;36:3882–3887 - PMC - PubMed

Publication types

MeSH terms

Associated data